IGFBP3 and metabolic dysfunction-associated steatotic liver disease: Therefore, low levels of IGF1 and low IGF1/IGFBP3 ratio (reflecting low IGF1 bioavailability) may be associated with the accumulation of lipids and advanced fibrosis in NAFLD (14).